US3789056A - A-phenylsuccinimido-halo-sulphonamido-benzenes - Google Patents

A-phenylsuccinimido-halo-sulphonamido-benzenes Download PDF

Info

Publication number
US3789056A
US3789056A US00047161A US3789056DA US3789056A US 3789056 A US3789056 A US 3789056A US 00047161 A US00047161 A US 00047161A US 3789056D A US3789056D A US 3789056DA US 3789056 A US3789056 A US 3789056A
Authority
US
United States
Prior art keywords
ethyl acetate
benzene
chloro
sulphamoyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00047161A
Other languages
English (en)
Inventor
R Pfirrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Application granted granted Critical
Publication of US3789056A publication Critical patent/US3789056A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones

Definitions

  • the compound a-ethyl-a-methyl-succinimide has been shown to be effective against the Petit Mal form of epilepsy but it is far less effective against the Grand Mal form and its effective dose level then approaches the toxic dose level.
  • the majority of the available anti-epileptic drugs are active against either Grand Mal or Petit Mal epilepsy but not against both forms.
  • R, R, R and R which may be the same or different are hydrogen atoms, aliphatic groups, cycloaliphatic groups or aryl groups or R and R or R and R may together represent a cycloalkylidene group, at least one of the substituents R, R, R and R being other than hydrogen;
  • R represents one or more halogen atoms
  • R and R which may be the same or different, are
  • heterocyclic groups such as pyridyl, pyrimidy] or imidazolyl groups, or aliphatic hydrocarbon groups which may, if desired, carry substituents such as x0, hydroxyl, carboxyl or esterified carboxyl, or aminoor aklylamino groups, or together with the nitrogen atom to which they are attached, form a heterocyclic group, e.g. a piperidyl or piperazyl group; and their salts with bases.
  • heterocyclic groups such as pyridyl, pyrimidy] or imidazolyl groups
  • aliphatic hydrocarbon groups which may, if desired, carry substituents such as x0, hydroxyl, carboxyl or esterified carboxyl, or aminoor aklylamino groups, or together with the nitrogen atom to which they are attached, form a heterocyclic group, e.g. a piperidyl or piperazyl group; and their salts with bases.
  • R is either a halogen atom such as bromine, or more preferably fluorine or most advantageously chlorine.
  • Compounds in which the sulphamoyl groups SO NR R is in the 4-position are especially preferred for their good anti-convulsant activity, especially those in which R is a chlorine or fluorine atom in the 2-position.
  • R and R may, for example, be alkyl groups having 1-5 carbon atoms, i.e. methyl, ethyl, propyl, butyl or amy] groups, acyl groups such as acetyl or benzoyl groups, alkoxycarbonyl groups such as ethoxy carbonyl groups, carbamyl groups e.g. the n-butylaminocarbonyl group, hydroxyalkyl groups, e.g. B-hydroxyethyl, or esterified carboxyalkyl groups e.g. ethoxycarbonylethyl groups.
  • the preferred compounds, however, are those in which R and R are both hydrogen.
  • the sulphonamido group is preferably in the 4-position relative to the succinimido group.
  • R, R R and R are aliphatic groups they are preferably alkyl or alkenyl groups, advanta geously having one to eight carbon atoms, more preferably one to five carbon atoms, for example, methyl, ethyl, propyl, butyl, amyl, hexyl, heptyl or allyl groups, which may carry substituents such as aryl groups, for example phenyl groups, which may be substituted as described below.
  • Such groups may thus include benzyl, phenethyl and phenylallyl groups one or more of R, R, R and R may be a cycloaliphatic group, for example a cycloalkyl or cycloalkenyl or two adjacent groups, i.e. R and R or R and R, may constitute together a cycloalkylidine group such as a cyclopentylidene or cyclohexylidene group.
  • Cycloalkyl groups may, for example, include cyclopentyl and cyclohexyl groups while cycloalkenyl groups may, for example, include cyclopentenyl and cyclohexenyl groups in which the double bond is in any of the available positions.
  • Such groups in general preferably contain three to eight carbon atoms, advantageously four to seven carbon atoms.
  • R, R R and R is aryl, or ar aliphatic, this may carry one or more alkoxy, methylene dioxy, nitro, cyano, acyl, carboxyl, esterified carboxyl, amino, alkylamino, sulphonamido or acylamido groups or halogen atoms.
  • the phenyl or chlorophenyl group is preferred.
  • R and R may advantageously be a methyl group and a hydrogen atom or ethyl or phenyl group respectively while R and R are preferably both hydrogen atoms; R is also advantageously a phenyl group while R, R and R are hydrogen atoms.
  • the new compounds form salts with bases, for example alkali metal salts e.g. sodium salts or salts with ammonia or amines.
  • bases for example alkali metal salts e.g. sodium salts or salts with ammonia or amines.
  • the compound l-(a-ethyl-a-methyl-succinimido)-2- chloro-4-sulphamoyl-benzene has shown especially favourable properties in our pharmacological tests as compared with l-(a-ethyl-a-methyl-succinimido)-4- sulphamoylbezene, which is the best compound disclosed in our said earlier cases.
  • the peroral LD of both compounds is of the order of 4000 mg/kg or greater in mice as compared with a-ethyl-a-methylsuccinimide which has a peroral LD in mice of about 1500 mg/kg.
  • the peroral ED of l-(a-ethyl-a-methyl-succinimido)-2-chloro-4- sulphamoylbenzene in mice was as low as 10 mg/kg while in albino rats the corresponding value was 5-10 mg/kg as compared with 5 mg/kg and 25 mg/kg respectively for the non-chlorinated sulphonamide.
  • a-Ethyl-a-methyl-succinimide shows an ED in the same tests of 500 mg/kg.
  • the peroral ED of l-(a-ethyl-amethylsuccinimido )-2-chloro-4-sulphamoyl-benzene was shown to be 50 mg/kg., as against 600 mg/kg for the unchlorinated sulphonamide and 200 300 mg/kg. for a-ethyl-a-methyl-succinimide; it will also be noted that 3 4 the ratio of ED ILD is significantly better for the benzene compound according to the invention.
  • we phamoyl-venzene provide pharmaceutical compositions containing one l-(a-cyclopentyl-succinimido)-2-chloro-4-sulphamor more compounds according to the invention tooyl-benzene gether with one or more pharmaceutical carriers or exl-(a-pentylsuccinimido)-2-chloro-4-sulphamoylcipients.
  • compositions may take the form of tablets, coated tablets, capsules, lozenges, suppositories, ampoules for injection, solutions, etc.
  • the carriers or excipients in such compositions may, for example be those conventional for such forms and may include starch, lactose, magnesium stearate, talc, gelatin, sterile pyrogen-free water, or suspending, emulsifying, dispersing, thickening or flavouring is reacted with a succinic acid derivative of the general formula HOOC CRR CR R" COOH ill or a reactive derivative thereof such as anhydride or a monoor diester, e.g. a lower alkyl ester, preferably having one to five carbon atoms, for example a methyl or ethyl ester, where R, R R R R R, R and R have the meanings given above, to form the desired succinimido derivative.
  • a succinic acid derivative of the general formula HOOC CRR CR R" COOH ill or a reactive derivative thereof such as anhydride or a monoor diester, e.g. a lower alkyl ester, preferably having
  • the reaction with the free succinic acid, anhydride or ester may be effected in a single stage, or in two stages.
  • the initial product will have the general formula (or its isomer in which the hemisuccinyl group is attached by the carbonyl adjacent to the groups R and R) and may be isolated, if desired, before final cyclisation.
  • the final condensation requires a reaction temperature of the order of 200C and for single stage condensations the reaction is preferably carried out between 100 and 200C.
  • the half-condensation of the succinic acid of formula IV generally takes place within the range 80 100C.
  • the initial condensation to form the product of formula IV is readily effected by merely heating in an inert solvent, e.g. a hydrocarbon, nitrohydrocarbon, chloro-hydrocarbon, ether or cyclic ether solvent.
  • an inert solvent e.g. a hydrocarbon, nitrohydrocarbon, chloro-hydrocarbon, ether or cyclic ether solvent.
  • the second stage to effect cyclisation may be effected, for example, in the presence of a dehydrating agent such as an anhydrous salt, e.g. sodium acetate, or sulphuric, phosphoric or polyphosphoric acid or phosphorus pentoxide or simply by heating in the temperature range 200C in the absence of a solvent with or without a vacuum.
  • the reaction time for the reaction with the free acid is preferably one to five hours, advantageously about 2 hours.
  • the one-stage reaction with the anhydride is preferably effected at about 200C for a short time.
  • the sulphonamido compounds according to the invention may also be prepared from corresponding compounds laclting a sulphonamido group by reaction with reagents for introducing a sulphonamido group.
  • a compound of formula I in which R represents an aryl or araliphatic group having no sulphonamido group may be reacted with a sulphonyl halide, to form a halosulphonyl derivative which may then be reacted with ammonia or an amine of the formula Nib-R 11 where R and R have the above meanings.
  • a halogenated succinimide-aminobenzene may be prepared by the reaction of the corresponding halogenated aminobenzene derivative with the acid of formula III or a reactive derivative thereof; if necessary the amino group may be protected before reaction.
  • acylation gives the acyl derivatives e.g. by reaction with an acyl halide or anhydride
  • alkylation gives the alkyl derivatives, e.g. by reaction with an alkyl halide, sulphate, sulphonate etc.
  • Hydroxylalkylation gives the hydroxyalkyl derivative, e.g. by reaction with ethylene oxide
  • carbamylation gives the corresponding urethane, e.g. by reaction with a carbonyl dihalide followed by reaction with ammonia or an amine.
  • Urethane derivatives can be prepared, for example, by reaction with a haloformic acid ester, e.g. a chloroformic acid ester, preferably an alkyl ester having one to five carbon atoms in the alkyl group.
  • Saturated substituents R R R or R can be prepared from corresponding unsaturated substituents and thus, for example, an n-propyl substituent can be prepared from an allyl substituent or a cycloalkyl substituent from a cycloalkenyl substituent by reduction, e.g. catalytic hydrogenation, for example using a platinium catalyst.
  • Example 3 1-( a-Methyl-a-ethyl-succinimido)-2- bromo-S-sulphamoyl benzene l-( a-Methyl-a-e thyl-succinimido )-2-bromobenzene (5.0 g) was added with stirring to chlorosulphonic acid (25 ml) and the mixture heated to 120C for 15 minutes. The mixture was then cooled, added dropwise to ice (250 g) and the preceipitated product collected.
  • Example 5 1-(a-Methyl-a-ethyl-succinimido)-2- chloro-4-sulphamoyl benzene a-Methyl-a-ethylsuccinic anhydride (15.0 g) and 3-chloro-4-aminobenzene sulphonamide (7.5 g) were heated together to an oil bath at 170-l 80 for 90 minutes, then at 220 for 30 minutes. The melt was cooled, dissolved in ethyl acetate and shaken with 1N sodium bicarbonate and with 2N hydrochloric acid. The ethyl acetate phase was then dried, charcoaled and mixed with petroleum ether.
  • Example 8 1-a-Methylsuccinimido-5-chloro-2- sulphamoyl benzene 2-Amino-4-chlorobenzenesulphonamide (2.0 g.) and a-methylsuccinic acid (1.3 g.) were heated together at 150C for 2 hours. The reaction mixture was cooled and dissolved in ethyl acetate. The solution was washed with 2N hydrochloric acid and with 1N sodium bicarbonate, dried and evaporated down to yield a brown oil (2.1 g.) which was dissolved in ether, filtered over charcoal and left to stand overnight. The precipitate was collected as white crystals (m.p. 176 182C) Recrystallisation from ethyl acetate/petroleum ether gave white crystals (m.p. 184/ 188C).
  • Example 9 1-(a-Methyl-a-ethylsuccinimido)-5-chloro- Z-sulphamoylbenzene 2-Amino-4-chlorobenzene sulphonamide (10.3 g.) and a-methyl-a-ethyl-succinic anhydride (7.1 g.) were heated together at 190C. The mixture was cooled and dissolved in ethyl acetate and shaken with 2N hydrochloric acid and with 1N sodium bicarbonate, dried and filtered over charcoal. The filtrate was mixed with petroleum ether and the precipitate collected as white crystals (6.5 g. m.p. l90200C).
  • Example 1 1 l-(a-Methyl-a-phenylsuccinimido)-2- bromo-4-sulphamoyl benzene 3-Bromo-4-anilino benzene sulphonamide (1.25 g.) and a-methyl-a-phenylsuccinic anhydride (0.95 g.) were heated together at 190C. for 1 hour. The cooled mixture was then dissolved in ethyl acetate, and the solution shaken with 1N sodium bicarbonate and with 2N hydrochloric acid, dried and evaporated down.
  • Example 1 7 1-(a-Methylsuccinimido)-2-fluoro-4-sulphamoyl-benzene 1.9 g of 3-fluoro-4-aminobenzene sulphonamide and 1.4 g of methylsuccinic acid are heated together for 1 hour at 160C. After cooling the melt is dissolved in ethyl acetate and extracted with 2N HCl and 1N NaH- C0 The ethyl acetate solution is dried with Na SO filtered over charcoal, somewhat concentrated and the residue mixed with petroleum ether, cooled and the precipitate suction filtered.
  • Example 19 1-(a-Phenylsuccinimido)-2-fluoro-4-(N- ethylsulphamoyl)-benzene a. l-amino-2-fluorobenzene-4-sulphonic ethylamide i. l-acetylamino-2-fluorobenzene-4-sulphonic acid chloride is added dropwise with stirring to excess ethylamine. The reaction solution is evaporated, the product taken up in ethyl acetate, washed with 2N HCl and the ethyl acetate solution evaporated again. Colourless crystals, m.p. 158160C ii.
  • Example 20 1-(a-Phenylsuccinimido)-2-chloro-4-(N- ethoxy-carbonylsulphamoyl)-benzene 3.6 g of 3-chloro-4-(a-phenylsuccinimido)-benzene sulphonamide and 36.30 g of potassium carbonate are suspended in 300 ml of acetone and subsequently 1.4 g of ethyl chloroformate is added. The mixture is refluxed for 15 hours, during which the suspension becomes slightly pink. After cooling, the inorganic salts are suction filtered and washed with a little acetone and the mother liquor is evaporated.
  • Example 21 l-(a-Cyclohex-en-l-yl-succinimido)-2- chloro-4-sulphamoyl-benzene (probably associated with some 1-(a,a-cyclohexylidenesuccinimido)-2- chloro-4-sulphamoyl-benzene) 5.0 g of 2-(cyclohex-en-1-yl)-mono-ethylsuccinate and 4.8 g of 2-chlorosulphani1amide are heated together for 7 hours in a N atmosphere, taken up in 200 ml of ethyl acetate and extracted as follows: (20 ml each) 3 times with 2N HCl, once with water, 3 times with 1N NaHCO once with water, and once with brine.
  • Example 22 1-(a-Phenylsuccinimido)-3,5-dichloro-4- sulphamoyl-benzene 12.0 g of 3,S-dichlorosulphanilamide and 9.6 g of phenyl succinic acid are intimately mixed and held for 8 hours in the autoclave at 220C under N After cooling, the mixture is dissolved in chloroform/ether 1:3 and extracted as follows: 5N HCl, 6 times with 40 ml; water, once with 50 ml; 1N NaHCO;,, 5 times with 50 ml; brine, once with 50 ml.
  • Example 23 l-(a-Pentylsuccinimido)-2-chloro-4-sulphamoyl-benzene 1.6 g of pentylsuccinic acid and 1.7 g of 2-chloro-4- sulphonamidoaniline are heated together for 40 minutes at 200C. The cooled dark brown solid product is dissolved in ether and extracted with 2N HCl and 1N NaHCO The ethereal solution is subsequently washed with water, filtered over activated charcoal, dried over sodium sulphate and evaporated Yield 1.4 g of light yellow oil. Recrystallisation once from ether petroleum ether Yields 0.95 g of almost white crystals, m.p. l32134C. Subsequent recrystallisation five times from ether petroleum ether gives crystals of m.p.
  • Example 24 1(a-Heptylsuccinimido)-2-chloro-4-sulphamoyl-benzene 10.0 g of heptylsuccinic acid and 10.5 g of 2-ch1oro- 4-sulphonamidoanilihe heated at 170C until no more water vapour distils off. The reaction mixture is then dissolved in 300 ml of ethyl acetate and extracted twice with 100 ml each of 2N HCl, 1N NaHCO and water. The ethyl acetate solution is dried over sodium sulphate, filtered over activated charcoal and evaporated.
  • Example 25 1-(a-Phenylsuccinimido)-2-chloro-4-N- acetyl-sulphamoyl-benzene 7.3 g of 3-chloro-4-(a-phenyl-succinimido)-benzenesulphonamide, 3.2 g of pyridine and 35 ml of acetic anhydride are refluxed together for 2% hours and subsequently evaporated in vacuo to yield 10.9 g of brown grease which is dissolved in ethyl acetate and extracted with 2N HCl and water. The ethyl acetate solution is dried over sodium sulphate and subsequently evaporated to yield 8.1 g of light beige solidified foam; m.p. 103-l C. A sample is recrystallised 3 times from water. A small quantity of the yield is sent for analysis; m.p. 1l0-115C Calc. C 53.18%; H 4.46%; N 6.83%; Found. C
  • Example 26 1-(a-n-Hexylsuccinimido)-2-chloro-4-sulphamoyl-benzene 2.0 g of n-hexylsuccinic acid and 2.0 g of 3-chlorosulphanilamide are heatedtogether in a boiling vessel via an oil bath, until no more water vapour can be distilled off. After cooling a brown grease remains which is dissolved in 100 ml of ethyl acetate and extracted twice each with 50 ml each of NaHCO solution, 2N HCl and water. The ethyl acetate solution is subsequently filtered hot over activated carbon and dried over sodium sulphate. After distilling off the ethyl acetate the remaining oil has a yellowish colour.
  • Example 27 1-(a-Phenylsuccinimido)-3-fluoro-4-sulphamoyl-benzene 5.0 g of 2-fluoro-4-aminosulphonamide and 5.1 g of phenylsuccinic acid are heated together for 3 hours at 190C. The mixture is taken up in ethyl acetate and washed 3 times with 2N l-lCl, once with water, 3 times with 1N NaHCO once with water, then subsequently extracted once with ethyl acetate, dried over Na SO evaporated and crystallised from ethyl acetateether. Yield 7.0 g m.p. 194-198C Recrystallised from ethyl l-198C Calc. C 55.13%; H 3.76%; N 8.04%; Found. C
  • Example 28 1-(wCyclohex-2-enylsuccinimido)-2- chloro-4sulphamoyl benzene 5.4 g of cyclohex-Z-enylsuccinic anhydride and 6.2 g of 3-chloro-4-aminobenzene sulphonamide are heated together to 200C. After cooling the mixture is dissolved in ethyl acetate and extracted with 2N HCl and 1N NaHCO dried and evaporated. Yield 9.5 g of brown oil, which is dissolved in ethyl acetate, filtered over charcoal, mixed with petroleum ether, cooled and suction filtered to yield white crystals of m.p.
  • Example 29 1-(a-Cyclopent-2-enylsuccinimido)-2'- chloro-4-su1phamoyl benzene 5.0 g of cyclopent-2-enyl-succinic anhydride and 6.2 g of 3-chloro-4-aminobenzene sulphonamide are heated together at 240C.
  • Example 30 1-(a-Methylsuccinimido)-3-fluoro-4-sulphamoyl-benzene acetate-ether, m.p.
  • Example 32 1-(a-Cyclopentylsuccinimido)-2-chloro-4- sulphamoyl benzene 3.5 g of (cyclopenten-Z-yl)-succinimide-2-chloro-4- sulphonamide benzene are dissolved in 50 ml of methanol and 0.1 g of PtO is added thereto. Hydrogenation duration 15 minutes: in theory 290 ml of H in practice 280 ml. The catalyst is removed and the solvent evaporated. The residue is a foam product which cannot be crystallised. Sample of the foam is supplied for analysis.
  • Example 33 1-(a-Allylsuccinimido)-2-chloro-4-sulphamoyl-benzene 5.6 g of allylsuccinic anhydride and 8.3 g of 3-chl0ro- 4-aminobenzene sulphonamide are heated together to 200C, kept at this temperature for 45 minutes, taken up in ethyl acetate, extracted with 2N HCl and 1N NaHCO dried with ethyl acetate and evaporated. Yield 10.6 g of brown oil, which is dissolved in a large volume of ether, filtered, concentrated to 250 ml, cooled and the precipitate suction filtered to give white crystals; m.p. 141-146C.
  • Example 35 1-(a-Methyl-a-phenylsuccinimido)-3- ch1oro-4-sulphamoyl benzene 5.5 g of 2-chloro-4-aminobenzene sulphonamide and 5.2 g of 3-methyl-3-phenylsuccinic anhydride are mixed and heated to 190C, cooled after 3 hours and taken up in ethyl acetate. The solution is washed 3 times with 2N HCl, once with water, 3 times lN NaH- CO once with water, twice with brine and back extracted once with ethyl acetate, dried over Na SO and evaporated to yield 8.8 g of dark brown oil.
  • Example 36 l-(a-Methyl-a-phenylsuccinimido)-2- chloro-S-sulphamoyl benzene 1.0 g of 3-amino-4-chlorobenzene sulphonamide and 0.95 g of a-phenyl-a-methylsuccinic anhydride are heated together to 210C, then dissolved in ethyl acetate, extracted with 2N HCl and 1N NaHCO dried with ethyl acetate, filtered over charcoal, crystallised with ether/petroleum ether, cooled and the precipitate suction filtered. Yield 1.0 g of white crystals; m.p. 1 10C which are recrystallised with acetone/etherpetroleum ether to yield white crystals; m.p. 9395C.
  • Example 37 1-(a-Methyl-a-phenylsuccinimido)-2- fluoro-4-(N-acetyl-sulphamoyl)-benzene 3.6 g of 3-fluoro-4-(a-methyl-a-phenylsuccinimide)-4-sulphamoyl-benzene and 1.6 g of pyridine (2 mol) are refluxed for 2 hours with 15 ml of acetic anhydride, and evaporated in vacuo. The brown oil is taken up in ethyl acetate, extracted with 2N HCl, dried and chromatographed neutral over 60 g neutral alumina.
  • Example 3 8 l-( a-Metnyl-oz-ethylsuccinimido 3- fluoro-4-sulphamoyl benzene 3.7 g of a-methyl-a-ethylsuccinic anhydride and 4.9 g of 2-fluoro-4-aminobenzene sulphonamide are heated together for 90 minutes at l90C, then taken up in ethyl acetate, extracted with 2N HCl and 1N NaHCO dried and evaporated. The residue is crystallised from acetone/petroleum ether to yield 4.3 .g of white crystals; m.p. l34l40C and then recrystallised from acetone/petroleum ether to yield white crystals; m.p. 141-143C Analysis Found. C
  • Example 39 1-(a-Methyl-a-ethylsuccinimido)-3- chloro-4-sulphamoyl-benzene 4.3 g of 2-chloro-4-aminobenzene sulphonamide and 3.0 g of 3-methyl-3-ethylsuccinic anhydride are mixed and heated for 1% hours at 200C, cooled and taken up in ethyl acetate, washed three times with 2N HCl, once with water, three times with 1N NaHCO once again with water, twice with brine, back-extracted once with ethyl acetate, dried over Na SO and evaporated to yield 6.95 g of brown oil which is filtered through charcoal in ethyl acetate-hexane and crystallised to yield 4.7 g; m.p.
  • Example 41 l-(a-Cyclohexylsuccinimido)-2-chloro-4- sulphamoyl-benzene 2. 8 g of (cyclohexen-2-yl)-succinimide-2- chlorobenzene-4-sulphonamide are dissolved in 50 ml of methanol, 0.1 g of Pt0 is added thereto and hydrogen passed in for 10 minutes, the uptake being in theory ml of H in practice ml. The catalyst is then removed, the solvent evaporated, the residue dissolved in ether and precipitated with petroleum ether and the preceipitate suction filtered to yield white crystals of m.p. l59l70C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
US00047161A 1969-06-18 1970-06-17 A-phenylsuccinimido-halo-sulphonamido-benzenes Expired - Lifetime US3789056A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3091569 1969-06-18

Publications (1)

Publication Number Publication Date
US3789056A true US3789056A (en) 1974-01-29

Family

ID=10315071

Family Applications (1)

Application Number Title Priority Date Filing Date
US00047161A Expired - Lifetime US3789056A (en) 1969-06-18 1970-06-17 A-phenylsuccinimido-halo-sulphonamido-benzenes

Country Status (11)

Country Link
US (1) US3789056A (enrdf_load_stackoverflow)
AT (1) AT309408B (enrdf_load_stackoverflow)
BE (1) BE752109A (enrdf_load_stackoverflow)
CH (1) CH540250A (enrdf_load_stackoverflow)
DE (1) DE2029821A1 (enrdf_load_stackoverflow)
ES (1) ES380854A1 (enrdf_load_stackoverflow)
FR (1) FR2052984B1 (enrdf_load_stackoverflow)
GB (1) GB1319772A (enrdf_load_stackoverflow)
NL (1) NL166016C (enrdf_load_stackoverflow)
SU (1) SU374821A3 (enrdf_load_stackoverflow)
ZA (1) ZA703784B (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177192A (en) * 1973-08-24 1979-12-04 Mobil Oil Corporation Succinimides of amino aromatic sulfonic acid salts
US4194982A (en) * 1978-07-03 1980-03-25 Texaco Inc. N-sulfonylated polyalkenylsuccinimide and lubricant composition
US4396548A (en) * 1977-06-27 1983-08-02 Ciba-Geigy Corporation Pyrazoline derivatives
US4588786A (en) * 1983-10-06 1986-05-13 Nippon Zeon Co., Ltd. Process for producing water-soluble dicarboxylic acid imide compounds
US5843989A (en) * 1994-06-10 1998-12-01 Smithkline Beecham P.L.C. C4 -amide substituted compounds and their use as therapeutic agents

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178455B (en) * 1979-07-17 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new 1-substituted-3-cycloalkyl-sulfonyl-pyrrolidine-2,5-dione derivatives

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6614740A (enrdf_load_stackoverflow) * 1965-10-19 1967-04-20
NL6717606A (enrdf_load_stackoverflow) * 1966-12-23 1968-06-24

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6614740A (enrdf_load_stackoverflow) * 1965-10-19 1967-04-20
NL6717606A (enrdf_load_stackoverflow) * 1966-12-23 1968-06-24

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177192A (en) * 1973-08-24 1979-12-04 Mobil Oil Corporation Succinimides of amino aromatic sulfonic acid salts
US4396548A (en) * 1977-06-27 1983-08-02 Ciba-Geigy Corporation Pyrazoline derivatives
US4194982A (en) * 1978-07-03 1980-03-25 Texaco Inc. N-sulfonylated polyalkenylsuccinimide and lubricant composition
US4588786A (en) * 1983-10-06 1986-05-13 Nippon Zeon Co., Ltd. Process for producing water-soluble dicarboxylic acid imide compounds
US5843989A (en) * 1994-06-10 1998-12-01 Smithkline Beecham P.L.C. C4 -amide substituted compounds and their use as therapeutic agents

Also Published As

Publication number Publication date
AT309408B (de) 1973-08-27
FR2052984B1 (enrdf_load_stackoverflow) 1974-08-09
ES380854A1 (es) 1973-04-01
GB1319772A (en) 1973-06-06
NL166016C (nl) 1981-06-15
NL7008893A (enrdf_load_stackoverflow) 1970-12-22
DE2029821A1 (de) 1970-12-23
FR2052984A1 (enrdf_load_stackoverflow) 1971-04-16
SU374821A3 (enrdf_load_stackoverflow) 1973-03-20
CH540250A (de) 1973-08-15
BE752109A (fr) 1970-12-17
NL166016B (nl) 1981-01-15
ZA703784B (en) 1971-04-28

Similar Documents

Publication Publication Date Title
CA1077496A (en) 4-(polyalkoxy-phenyl)-2-pyrrolidone ii
NZ202903A (en) 1-- pe pyrrol-2-yl-carboxylic acid derivatives and pharmaceutical compositions
GB1575709A (en) 1,1-cycloalkyldiacetic acid imide derivatives and their use for preparing 1-aminomethyl-1-cycloalkylacetic acids
SU508199A3 (ru) Способ получени производных морфолина
US3789056A (en) A-phenylsuccinimido-halo-sulphonamido-benzenes
US3267117A (en) Novel substituted indol-5-ols
US4803198A (en) 1-Phenyl-2-aminocarbonylindole compounds, preparation thereof and pharmaceutical compositions containing them
US4124593A (en) Aromatic dicarboximides
US3933802A (en) New sulphamoylbenzoic acid amides
IE45511B1 (en) New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
JPS61109766A (ja) アダマンタンアミン誘導体、その製造方法及びそれを含む医薬
US4937260A (en) Benzamido-derivatives
US3813387A (en) Sulphamoylphenyl pyrrolidinones
DE3823919A1 (de) 3-substituierte benzazepine
HU205116B (en) Process for producing 1,4-diazabicyclo/3.2.2./nonane
SU910118A3 (ru) Способ получени N @ -глюкофуранозид-6-ил-N @ -нитрозомочевины
US3644398A (en) 1-carbamoyl-3-phenylpyrrolidines
US3542807A (en) 1-(omega-benzoylalkyl)-3-substituted pyrrolidines
US3775401A (en) Alpha-aryl-succinimide-sulphonamide derivatives
US3449346A (en) Benzenesulfonyl ureas
US2945860A (en) New piperazine-carboxylic acid esters
US4204998A (en) N-Amino indole derivatives having pharmacological activity
US3574194A (en) 1-alpha-ethyl - alpha - methyl-succinimido) -4-sulphonamidobenzene and related compounds
US3458498A (en) Certain 1-acyl derivatives of 7-alkoxy-2,3,4,5-tetrahydro-1h-1-benzazepine
EP0663395B1 (de) 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als herzfrequenzsenkendes Mittel